Cardiac stunning as first manifestation of multiple sclerosis: A case report reminding us not to overlook cardiovascular autonomic dysfunction in multiple sclerosis by Hilz, MJ
Clinical commentary 
Cardiac stunning as first manifestation of multiple sclerosis: A case report reminding us not to 
overlook cardiovascular autonomic dysfunction in MS 
Max J. Hilz 
Department of Neurology, University of Erlangen-Nuremberg, Germany 
Corresponding author: Max J. Hilz  
Department of Neurology, University of Erlangen-Nuremberg 
Schwabachanlage 6, D-91054 Erlangen, Germany 
Phone: +49-9131-853-4444 
Fax:     +49-9131-853-4328 
E-mail: max.hilz@uk-erlangen.de 
 
Abstract:  
Autonomic dysfunction is common but frequently overlooked in multiple sclerosis (MS) patients.  The 
case of a Tako-Tsubo cardiomyopathy on which this commentary is based shows that centrally 
triggered autonomic dysfunction may be the first, life-threatening manifestation of MS.  
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Autonomic dysfunction is known to contribute to disability in multiple sclerosis (MS) patients.1  
Up to 84% of MS patients experience dysfunction of autonomic organ regulation.1 Common 
complaints include bowel and bladder disturbances, sexual dysfunction, or sweating abnormalities.1, 2 
Cardiovascular autonomic dysfunction may include baroreflex dysfunction with orthostatic intolerance 
and orthostatic hypotension, postural tachycardia syndrome or decreased heart rate variability3 which 
is associated with an increased risk of cardiovascular complications and reduced life expectancy. 3, 4 
Although autonomic dysfunction frequently impairs the patient’s quality of life,3 autonomic 
dysregulation and its prognostic impact seem to be poorly addressed in the clinical evaluation of MS 
patients. The most common scales evaluating MS severity, the Expanded Disability Status Scale 
(EDSS)5 and Multiple Sclerosis Functional Composite (MSFC)6 largely ignore the clinical and 
prognostic relevance of autonomic dysfunction.  
This is remarkable since the autonomic nervous system is not only afflicted by the neuro-inflammatory 
process but may even contribute to maintaining inflammation and disease progression.7 MS induced 
changes in sympathetic or parasympathetic modulation may in turn alter immune responses.7 
Particularly during the first years after disease manifestation, MS patients seem to have an increased 
risk of cardiovascular diseases8 which is very likely to be due to a central up-regulation of sympathetic 
outflow to the cardiovascular system.7 
Still, acute cardiovascular emergencies are rarely recognized as initial manifestation of MS, probably 
because cardiologists and neurologists are unaware of this etiology. 
However, sympathetic activity may increase significantly during early stages of MS while later 
relapses may lead to progressive noradrenergic failure and adrenergic receptor dysfunction. 7 In stroke 
patients, neurologists are increasingly aware of the risk of abundant cardiovascular autonomic 
disorders9, 10 In contrast, acute cardiologic emergencies might not be recognized as centrally mediated 
in patients who experience such an emergency, and, supposedly by coincidence, also happen to have 
MS.  
In this issue of the MSJ , Madaglia et al. present the case of a previously healthy young man who was 
admitted to internal medicine because of severe headache and diaphoresis and a first-degree 
atrioventricular block.11 Two weeks later, symptoms reoccurred but were more severe, with additional 
tachycardia- and dyspnoea, arterial hypertension, and electrocardiographic changes that are typical for 
stress-cardiomyopathy,12 also called Tako-Tsubo cardiomyopathy (TTC). TTC may be life threatening 
and is characterized by apical ballooning, left ventricular dysfunction with ventricular wall-motion 
abnormalities.12, 13  Although the pathogenesis of TTC is not yet fully understood,12 there is a 
dysfunction in the brain-heart axis, most likely with increased sympathetic activity and catecholamine 
surges.13  The patient had no myocarditis or acute myocardial infarction but turned out to have MS 
with several active lesions, some of which involved areas of the central autonomic network e.g. the 
medulla oblongata. Methylprednisolone treatment quickly reversed the myocardial stunning. 
The case alerts neurologists to the fact that MS may manifest as cardiovascular emergency3. Although 
it seems to be the first report of TTC as the initial symptom of MS, cardiovascular complications of 
MS are frequent and range from subclinical to life-threatening events, and may cause fatalities that 
have been coined as “SUDIMS”, Sudden Unexpected Death in MS,3 in analogy to “SUDEP”, the 
Sudden Unexpected Death in Epilepsy.14 
In summary, the case reminds us to pay closer attention to centrally mediated autonomic dysfunction 
in MS patients and to better investigate the association between neuro-inflammation and 
cardiovascular autonomic dysfunction.  
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